The coronavirus disease 2019 (COVID-19) pandemic has caused several waves of infections in many world regions, so strong as to overwhelm local healthcare services. In this new situation, faced with an unknown virus, the need is to produce clinical guidelines that help recognize and manage critical COVID-19. Meanwhile, conditions such as chronic obstructive pulmonary disease (COPD) are linked to a markedly increased risk of death in community pneumonia.
A new preprint available on the bioRxiv* preprint server uses computational algorithms to tease out the interrelationships between these two conditions that cause similar outcomes. Based on protein-protein interactions (PPIs), the paper shows the presence of ten genes that overlap between the two illnesses, also shared by several other deadly and debilitating diseases.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread worldwide and has led to approximately five million deaths so far. Older adults are by far the worst affected by COVID-19, with this illness accounting for 80% of all deaths in the 65-and-above age group.
Interestingly, this age group is also at the highest risk of COPD. In this condition, found in a tenth of people over 40 years, the airflow is limited, mostly caused by chronic bronchitis or emphysema. Many genetic and environmental factors play a part in the occurrence of this disease, including irritant chemical inhalation or smoking, though only about a fifth of smokers have COPD.
While COPD patients rarely acquire COVID-19, the risk of death is much higher than non-COPD patients. Accordingly, recent recommendations have been made to update the diagnostic and treatment protocols for COPD.
Independent of COVID-19, COPD is responsible for the third-largest number of deaths in the world. Considered a polygenic condition, it renders its victims susceptible to severe disease and death following the triggering of a cytokine storm by SARS-CoV-2 infection.
The latter causes symptoms only after about five days, with death, if it occurs, taking place at an average of 14 days later, depending on the patient’s age and immunity.
However, COPD is a treatable condition, if not curable, with current therapies able to maintain a high quality of life and keep the patient safe from other respiratory illnesses. When it coexists with COVID-19, the respiratory tract suffers because of the pre-existing lung injury. Thus, severe COVID-19 is fourfold more likely in such patients.
COPD patients have higher levels of the viral entry receptor, the angiotensin-converting enzyme 2 (ACE2), as do smokers.
What did the study show?
The researchers constructed a PPI network using available data on ~5,500 COVID-19 and 296 COPD gene expression profiles to elucidate the genes involved in such complicated conditions.
They first identified 248 overlapping genes, of which ten were found to be the top common genes. These are implicated in cell-cell communication and metabolism, development, the response to stimuli, and biological regulation. These genes are mostly also involved in pathways implicated in malaria, trypanosomiasis, and inflammatory bowel disease (IBD).
The Interleukin 10 (IL 10) gene is the first common gene, or the hub gene, expressing a regulatory cytokine that modulates the inflammatory response. It is markedly upregulated in associated with the cytokine storm in severe COVID-19 patients admitted to the intensive care unit (ICU).
It is, however, low in patients with COPD who have dramatic airway inflammation. IL-10 thus serves as a marker of disease severity and is useful for monitoring treatment.
The study similarly elucidates the role of Toll-like receptor 4 (TLR4), expressed by multiple immune cells and found to be required for the initiation of inflammatory responses. When it increases excessively, hyperinflammation may set in.
The TLRs are driven by the recognition of viral RNA or dsDNA intermediate forms (called pathogen-associated molecular patterns (PAMPs). These are formed from the viral genome and recognized by pattern recognition receptors, especially the TLRs, triggering further inflammatory antiviral cascades that eventually clear the virus.
TLR4 is found to have the highest PPI with the viral spike protein compared to other TLRs. SARS-CoV-2 is found to enhance the expression of interferon-stimulated genes (ISGs) in the respiratory tract. However, the higher levels of ISG expression can cause greater ACE2 expression as well. Research shows how lung surfactants block the infection by TLR4 binding and activation.
Other hub genes include the Tumor necrosis factor (TNF), a key inflammatory mediator that is elevated in acute inflammation due to viral infection, and chronic or systemic inflammation. High TNF levels are found in patients with COPD and patients with acute COVID-19 and COPD.
Fourthly, IL6 is a potent inflammatory cytokine, with multiple actions in the inflammatory cascade. It is produced by many cell types, including epithelial airway cells and alveolar macrophages. High IL6 levels are associated with worse lung function and an accelerated rate of deterioration and skeletal muscle weakness in COPD.
IL8, also known as CXCL8, is a mediator for neutrophil tracking and is implicated in inflammatory processes, notably after viral infections. Respiratory muscle weakness in patients with COPD is traceable in part to IL8 activity, with rises in the level of this cytokine during COPD exacerbations. High CXCL8 levels are suggested to be the cause of death in severe COVID-19.
IL4 is an activator of the JAK-STAT pathway that drives inflammation and mediates hyper-responsiveness of the airways, a key COPD element.
The seventh hub gene is ICAM1, an intercellular adhesion molecule that is overproduced during early inflammation, causing the premature release of neutrophils. This molecule is elevated in COPD patients. With moderate to severe COVID-19, ICAM1 levels are high and increasing but drop in convalescence.
This may mean that these molecules are markers of COVID-19 severity. Besides, they also trigger coagulation defects. The four intracellular binding sites for SARS-CoV-2 within human cells are highly expressed in COPD patients.
The eighth hub gene is interferon-gamma (IFN-γ). This is known to be a key risk gene for COVID-19 patients with lung disease. COPD patients have a more than five times higher risk of severe COVID-19
TLR2 is the ninth hub gene, associated with a decline in lung function and evidence of inflammation in sputum, indicating its role in COPD pathogenesis and exacerbation. It is also known to recognize SARS-CoV-2 particles and may be part of the infection-pulmonary embolism pathway.
The last of the hub genes is IL18, which is thought to be tied to the abnormal inflammatory pathways in COPD. Anti-IL 18 antibodies neutralize the damage and inflammation caused by COPD in preclinical models.
News
Common Medication Could Save Half a Million Lives Each Year – So Why Isn’t It?
A recent study conducted by scientists at the University of Southern California sheds light on the reasons why children are not receiving an affordable and effective diarrhea treatment. Medical professionals in developing nations are [...]
X Marks the Spot: AI’s Treasure Maps Lead to Early Disease Detection
Medical diagnostics expert, doctor’s assistant, and cartographer are all fair titles for an artificial intelligence model developed by researchers at the Beckman Institute for Advanced Science and Technology. Their new model accurately identifies tumors [...]
Scientists Discover Method To Identify Alzheimer’s Disease Before It Progresses to Dementia
Researchers at Aarhus University have discovered a method to identify Alzheimer’s disease before it progresses to dementia, potentially opening up new avenues for treatment. A groundbreaking study could pave the way for early detection [...]
Startling Discovery: COVID-19 Virus Can Stay in the Body More Than a Year After Infection
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research from UC San Francisco that offers potential [...]
New bioengineered protein design shows promise in fighting COVID-19
In the wake of the COVID-19 pandemic, scientists have been racing to develop effective treatments and preventatives against the virus. A recent scientific breakthrough has emerged from the work of researchers aiming to combat [...]
Sugar-coated gold nanoparticles can quickly eliminate bacterial infections, no antibiotics required
If left to their own devices, bacteria on our teeth or wounded skin can encase themselves in a slimy scaffolding, turning into what is called biofilm. These bacteria wreak havoc on our tissue and, [...]
Liquid Lightning: Nanotechnology Unlocks New Energy
EPFL researchers have discovered that nanoscale devices harnessing the hydroelectric effect can harvest electricity from the evaporation of fluids with higher ion concentrations than purified water, revealing a vast untapped energy potential. Evaporation is a natural [...]
Unmasking the Illusion: AI-Generated Faces Challenge Perceptions
Research shows survey participants duped by AI-generated images nearly 40 percent of the time. If you recently had trouble figuring out if an image of a person is real or generated through artificial intelligence [...]
New Discovery Reveals How Cells Defend Themselves During Stressful Situations
Stress granules play a crucial role in the stress response, arising from the aggregation of non-translating mRNAs and proteins. Although significant knowledge exists about stress granules, the mechanisms behind their mRNA localization remain partially [...]
Scientists use a new type of nanoparticle that can both deliver vaccines and act as an adjuvant
Many vaccines, including vaccines for hepatitis B and whooping cough, consist of fragments of viral or bacterial proteins. These vaccines often include other molecules called adjuvants, which help to boost the immune system's response [...]
Not Science Fiction: How Optical Neural Networks Are Revolutionizing AI
A novel architecture for optical neural networks utilizes wavefront shaping to precisely manipulate the travel of ultrashort pulses through multimode fibers, enabling nonlinear optical computation. Present-day artificial intelligence systems rely on billions of adjustable [...]
Turning skin cells into limb cells sets the stage for regenerative therapy
In a collaborative study, researchers from Kyushu University and Harvard Medical School have identified proteins that can turn or “reprogram” fibroblasts — the most commonly found cells in skin and connective tissue — into [...]
AI reveals prostate cancer is not just one disease
Artificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer, which could revolutionise how the disease is diagnosed and treated in the future. A Cancer Research UK-funded study, published in Cell Genomics, has revealed [...]
New Study Finds That Persistent COVID-19 Infections Are Surprisingly Common
Recent research conducted by the University of Oxford has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more. The findings have been published in the journal Nature. [...]
Innovative nanosheet method revolutionizes brain imaging for multi-scale and long-term studies
The human brain has billions of neurons. Working together, they enable higher-order brain functions such as cognition and complex behaviors. To study these higher-order brain functions, it is important to understand how neural activity [...]
Scientists Have Discovered a Potential Universal Antivenom
Scientists at Scripps Research identified antibodies that protect against a host of lethal snake venoms. Scripps Research scientists have developed an antibody that can block the effects of lethal toxins in the venoms of [...]